Literature DB >> 6345379

Activation of plasma kallikrein-kinin system and its significant role in pleural fluid accumulation of rat carrageenin-induced pleurisy.

Y Uchida, K Tanaka, Y Harada, A Ueno, M Katori.   

Abstract

Rat pleurisy was induced by intrapleural injection of lambda-carrageenin. The pleural exudate began to be accumulated 1-3 h after carrageenin administration and showed a peak at 19 h. The levels of prekallikrein and high-molecular-weight (HMW), but not low-molecular-weight (LMW), kininogen in the pleural fluid were markedly decreased when compared with those in plasma. Prekallikrein in rat plasma was activated by incubation with carrageenin in vitro. Captopril increased the plasma exudation significantly at 1-5 h. Depletion of prekallikrein and HMW kininogen in rat plasma by preadministration of bromelain caused marked inhibition of the plasma exudation at 1-24 h. The rest of the plasma exudation after bromelain was further decreased by simultaneous pretreatment of rats with both bromelain and aspirin. These results clearly indicate that plasma prekallikrein was activated in the pleural cavity and bradykinin released was responsible for plasma exudation during the entire course of this pleurisy.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6345379     DOI: 10.1007/bf00917817

Source DB:  PubMed          Journal:  Inflammation        ISSN: 0360-3997            Impact factor:   4.092


  10 in total

1.  Fluorometric assay for plasma prekallikrein using peptidymethyl-coumarinyl-amide as a substrate.

Authors:  S Oh-ishi; M Katori
Journal:  Thromb Res       Date:  1979       Impact factor: 3.944

2.  Protein measurement with the Folin phenol reagent.

Authors:  O H LOWRY; N J ROSEBROUGH; A L FARR; R J RANDALL
Journal:  J Biol Chem       Date:  1951-11       Impact factor: 5.157

3.  Prostaglandins, aspirin-like drugs and the oedema of inflammation.

Authors:  S Moncada; S H Ferreira; J R Vane
Journal:  Nature       Date:  1973-11-23       Impact factor: 49.962

4.  Carrageenan and delayed hypersensitivity. II. Activation of Hageman factor by carrageenan and its possible significance.

Authors:  H J Schwartz; R W Kellermeyer
Journal:  Proc Soc Exp Biol Med       Date:  1969-12

5.  Bovine plasma kininogens. III. Structural comparison of high molecular weight and low molecular weight kininogens.

Authors:  M Komiya; H Kato; T Suzuki
Journal:  J Biochem       Date:  1974-10       Impact factor: 3.387

6.  Differential assay method for high molecular weight and low molecular weight kininogens.

Authors:  Y Uchida; M Katori
Journal:  Thromb Res       Date:  1979       Impact factor: 3.944

7.  Bromelian, a thiolprotease from pineapple stem, depletes high molecular weight kininogen by activation of Hageman factor (Factor XIII).

Authors:  S Oh-ishi; Y Uchida; A Ueno; M Katori
Journal:  Thromb Res       Date:  1979       Impact factor: 3.944

8.  Potentiation of bradykinin-induced vascular permeability increase by prostaglandin E2 and arachidonic acid in rabbit skin.

Authors:  K Ikeda; K Tanaka; M Katori
Journal:  Prostaglandins       Date:  1975-11

9.  Prostaglandin E2, prostaglandin I2 and the vascular changes of inflammation.

Authors:  T J Williams
Journal:  Br J Pharmacol       Date:  1979-03       Impact factor: 8.739

10.  Changes in the levels of prostaglandins and thromboxane and their roles in the accumulation of exudate in rat carrageenin-induced pleurisy--a profile analysis using gas chromatography-mass spectrometry.

Authors:  Y Harada; K Tanaka; Y Uchida; A Ueno; S Oh-Ishi; K Yamashita; M Ishibashi; H Miyazaki; M Katori
Journal:  Prostaglandins       Date:  1982-06
  10 in total
  7 in total

1.  Determination of bradykinin-(1-5) in inflammatory exudate by a new ELISA as a reliable indicator of bradykinin generation.

Authors:  M Majima; K Nishiyama; Y Iguchi; K Yao; M Ogino; T Ohno; N Sunahara; K Katoh; N Tatemichi; Y Takei; M Katori
Journal:  Inflamm Res       Date:  1996-08       Impact factor: 4.575

2.  New synthetic antagonists of bradykinin.

Authors:  M Schachter; Y Uchida; D J Longridge; T Labedz; E T Whalley; R J Vavrek; J M Stewart
Journal:  Br J Pharmacol       Date:  1987-12       Impact factor: 8.739

3.  Bradykinin down-regulates LPS-induced eosinophil accumulation in the pleural cavity of mice through type 2-kinin receptor activation: a role for prostaglandins.

Authors:  A R Silva; A P Larangeira; P Pacheco; J B Calixto; M G Henriques; P T Bozza; H C Castro-Faria-Neto
Journal:  Br J Pharmacol       Date:  1999-05       Impact factor: 8.739

4.  Increased migration of neutrophils to granulocyte-colony stimulating factor in rat carrageenin-induced pleurisy: roles of complement, bradykinin, and inducible cyclooxygenase-2.

Authors:  M Ogino; M Majima; M Kawamura; K Hatanaka; M Saito; Y Harada; M Katori
Journal:  Inflamm Res       Date:  1996-07       Impact factor: 4.575

5.  Evidence for the involvement of a plasma kallikrein-kinin system in the immediate hypotension produced by endotoxin in anaesthetized rats.

Authors:  M Katori; M Majima; R Odoi-Adome; N Sunahara; Y Uchida
Journal:  Br J Pharmacol       Date:  1989-12       Impact factor: 8.739

6.  Activation of the plasma kallikrein-kinin system by Vibrio vulnificus protease.

Authors:  N Miyoshi; S Miyoshi; K Sugiyama; Y Suzuki; H Furuta; S Shinoda
Journal:  Infect Immun       Date:  1987-08       Impact factor: 3.441

7.  Involvement of the kinin-generating cascade in enhanced vascular permeability in tumor tissue.

Authors:  Y Matsumura; M Kimura; T Yamamoto; H Maeda
Journal:  Jpn J Cancer Res       Date:  1988-12
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.